5th annual hematology and medical oncology … · 5th annual hematology and medical oncology board...

7
5 th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research Center 417 East 68th Street New York, NY 10065

Upload: phamque

Post on 25-Aug-2018

255 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

5th AnnualHematology and Medical Oncology Board Review: Contemporary Practice

Friday-Monday, March 10-13, 2017Zuckerman Research Center417 East 68th StreetNew York, NY 10065

Page 2: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

OBJECTIVES

• State-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers

• State-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers

• Recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

AUDIENCE

Physicians who are either oncology fellows in training or practicing oncologists in both academic and private practice.

David H. Ilson, MD, PhDAttending Physician, Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Craig H. Moskowitz, MDSteven A. Greenberg Chair in Lymphoma Research Clinical Director, Division of Hematologic OncologyAttending Physician, Lymphoma and Adult BMT ServicesDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Program Overview

MSK Course Directors

Page 3: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

Ghassan K. Abou-Alfa, MD Associate Attending Physician Gastrointestinal Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Carol Aghajanian, MDAttending Physician, Chief Gynecologic Medical Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Dean F. Bajorin, MDAttending Physician Genitourinary Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

George J. Bosl, MDAttending Physician Genitourinary Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Paul B. Chapman, MDAttending Physician Melanoma and Sarcoma ServiceDivision of Solid Tumor Oncology Department of Medicine

Andrea Cercek, MDAssistant Attending Physician Gastrointestinal Oncology Service Division of Solid Tumor Oncology Department of Medicine

Chau T. Dang, MD Chief, West Harrison Medical Oncology ServiceBreast Medicine ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Maura N. Dickler, MD Interim Chief, Breast Medicine ServiceSection Head, Endocrine Therapy Clinical Research ProgramAssociate Member, Memorial Sloan Kettering Cancer CenterDivision of Solid Tumor OncologyDepartment of MedicineAssociate Professor of Medicine, Weill Cornell Medical College

Mark A. Dickson, MD Assistant Attending Physician Sarcoma Medical Oncology Service Division of Solid Tumor Oncology Department of Medicine

Sergio A. Giralt, MDChief, Adult Bone Marrow Transplant ServiceDivision of Hematologic OncologyDepartment of Medicine

Mrinal M. Gounder, MD Assistant Attending PhysicianSarcoma Medical Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Christian Grommes, MDAssistant Attending PhysicianNeurology ServiceDepartment of Neurology

Hani Hassoun, MDAssociate Attending PhysicianMyeloma ServiceDivision of Hematologic OncologyDepartment of Medicine

Bob T. Li, MD, MPHAssistant Attending PhysicianThoracic Oncology Service, Developmental TherapeuticsDivision of Solid Tumor OncologyDepartment of Medicine

Simon Mantha, MD, MPHAssociate Attending Physician Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

Michael J. Mauro, MDAttending PhysicianLeukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Beryl McCormick, MD, FACRChief, External Beam Radiotherapy ServiceBrachytherapy ServiceDepartment of Radiation Oncology

Monica Morrow, MD, FACSAnne Burnett Windfohr Chair of Clinical Oncology Chief, Breast Surgical ServiceDepartment of SurgeryProfessor of Surgery, Weill Cornell Medical College

Robert J. Motzer, MDAttending Physician Genitourinary Oncology ServiceDivision of Solid Tumor Oncology Department of Medicine

Eileen M. O’Reilly, MDAssociate Director for Clinical Research,David M. Rubenstein Center for Pancreatic CancerAttending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor Oncology Department of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

David G. Pfister, MDAttending Physician, Chief Head and Neck Oncology ServiceDivision of Solid Tumor Oncology Department of Medicine

Dana Rathkopf, MDAssociate Attending PhysicianGenitourinary Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Gregory J. Riely, MD, PhDVice Chair, Clinical Trials OfficeAssociate Attending PhysicianThoracic Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Paul Sabbatini, MDDeputy Physician-in-Chief for Clinical ResearchGynecologic Medical Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Leonard B. Saltz, MDChief, Gastrointestinal Oncology ServiceHead, Colorectal Oncology Section Division of Solid Tumor OncologyDepartment of MedicineProfessor of Medicine, Weill Cornell Medical College

Andrew D. Seidman, MDAttending Physician Breast Cancer Medicine ServiceDivision of Solid Tumor Oncology Department of Medicine

Susan K. Seo, MDAssociate Attending Physician Infectious Disease ServiceDivision of General Medicine Department of Medicine

Gerald A. Soff, MDChief, Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

David B. Solit, MDGeoffrey Beene ChairDirector, Marie-Josée and Henry R. Kravis Center for Molecular OncologyGenitourinary Oncology ServiceDivision of Solid Tumor Oncology Department of MedicineMember, Human Oncology andPathogenesis Program (HOPP)

Zsofia K. Stadler, MDAssistant Attending PhysicianClinical Genetics & Gastrointestinal Oncology ServicesDivision of Solid Tumor OncologyDepartment of Medicine

Martin S. Tallman, MDChief, Leukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Anas Younes, MDChief, Lymphoma ServiceDivision of Hematologic OncologyDepartment of Medicine

Anna M. Varghese, MDAssistant Attending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Marjorie G. Zauderer, MDAssistant Attending Physician Thoracic Oncology ServiceDivision of Solid Tumor Oncology Department of Medicine

Andrew D. Zelenetz, MD, PhDMedical Director, Quality InformaticsAttending PhysicianLymphoma ServiceDivision of Hematologic OncologyDepartment of Medicine

MSK Faculty

Page 4: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

DAY 1 Friday, March 10, 2017

7:00 am REGISTRATION & BREAKFAST

8:00 am Department of Medicine Grand Rounds:

Clinical Application of Next Generation Sequencing as a Guide to Treatment Selection David B. Solit, MD

9:00 am Colon Cancer Leonard B. Saltz, MD

10:00 am Melanoma Paul B. Chapman, MD

10:45 am Prostate Cancer Dana Rathkopf, MD

11:30 am Kidney Cancer Robert J. Motzer, MD

12:15 pm LUNCH

1:15 pm Urothelial Cancer Dean F. Bajorin, MD

2:00 pm Testis Cancer George J. Bosl, MD

2:45 pm Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD

3:30 pm BREAK

3:45 pm Ovarian Cancer Paul Sabbatini, MD

4:30 pm Breast Cancer/Surgery Monica Morrow, MD, FACS

5:00 pm Breast Cancer/Radiation Therapy Beryl McCormick, MD, FACR

5:30 pm Non-Small Cell Lung Cancer Gregory J. Riely, MD, PhD

Scientific Agenda

Page 5: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

DAY 2 Saturday, March 11, 2017

6:30 am BREAKFAST

7:00 am Breast Cancer/Hormonal Therapy Maura N. Dickler, MD

7:30 am Breast Cancer/Advanced Disease Andrew D. Seidman, MD

8:30 am Breast Cancer/Adjuvant Therapy Chau T. Dang, MD

9:30 am Small Cell Lung CancerBob T. Li, MD, MPH

10:00 am Carcinoma of Unknown Primary Anna M. Varghese, MD

10:30 am BREAK

10:45 am Hepatocellular Cancer and Cholangiocarcinoma Ghassan K. Abou-Alfa, MD

11:30 am Pancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD

12:15 pm Mesothelioma Marjorie G. Zauderer, MD

12:30 pm LUNCH

1:15 pm Gastric and Esophagus Cancer David H. Ilson, MD, PhD

2:00 pm Head and Neck, Thyroid Cancer David G. Pfister, MD

2:45 pm Anal/Rectal Cancer Andrea Cercek, MD

3:15 pm BREAK

3:30 pm Genetics Zsofia K. Stadler, MD

4:00 pm CNS Tumors Christian Grommes, MD

4:30 pm Sarcoma Mark A. Dickson, MD

5:00 pm Infectious Disease Susan K. Seo, MD

Scientific Agenda

Page 6: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

DAY 3 Sunday, March 12, 2017

7:00 am BREAKFAST

7:30 am Pharmacology I and II Mrinal M. Gounder, MD

9:00 am AML/ALL Martin S. Tallman, MD

10:00 am MDS/MPN Michael J. Mauro, MD

11:00 am Myeloma/Amyloid Hani Hassoun, MD

12:00 pm LUNCH 1:00 pm Low Grade NHL/CLL

Andrew D. Zelenetz, MD, PhD

2:00 pm DLBCL/MCL/BL Anas Younes, MD

3:00 pm HL/T Cell Craig H. Moskowitz, MD

4:00 pm Auto/Allo Sergio A. Giralt, MD

DAY 4 Monday, March 13, 2017

Benign Heme

7:30 am BREAKFAST

8:00 am An Approach to Bleeding Disorders Gerald A. Soff, MD

9:00 am Thrombocytopenia For the Oncologist.  Beyond ITP Gerald A. Soff, MD

10:00 am The Current Status of the New Direct Oral Anticoagulants Simon Mantha, MD, MPH

11:00 am Adjourn

Scientific Agenda

Page 7: 5th Annual Hematology and Medical Oncology … · 5th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Friday-Monday, March 10-13, 2017 Zuckerman Research

Physicians (MDs, PhDs and DOs) $1,400

Fellows, Residents and RNs $875

Industry Members* $2,450

REGISTER ONLINE:

www.mskcc.org/hemoncreviewcourseRegistration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

30% Discounted Rate for MSK Alumni and MSK Alliance Members MSK offers a 30% discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for a promo code or more information.

MSK Staff Registration Registration is complimentary for MSK staff who wish to attend this course. However, you must register online by visiting the course website.

*Industry Members Registration is for educational purposes only. Marketing, sales, and promotion of products and services are prohibited at CME activities.

ACCREDITATION STATEMENT MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENTMSK designates this live activity for a maximum of 29.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

MOC POINTSSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 29.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCOMMODATIONSFor information regarding traveling to MSK, including hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/cme.

CONTINUING MEDICAL EDUCATIONMEMORIAL SLOAN KETTERING CANCER CENTER

633 Third Avenue, 12th Floor, New York, NY 10017www.mskcc.org/cme | [email protected]

/MSKCME @MSKCME MSK CME LinkedIn Group

Cover Image Source: Alex Ritter, Jennifer Lippincoll Schwartz and Gillian Griffiths, National Institutes of Health (www.goo.gl/A9xKAc)

Registration